MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-02-0038180
Repro Labs India Private Limited - healthcare in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹22.62 Cr
▲ 10% YoY
Net profit · FY 2025
₹31.89 Lakh
Net margin 1.4%
EBITDA · FY 2025
₹88.95 Lakh
EBITDA margin 3.9%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹5.75 Cr
Secured borrowings
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings
About Repro Labs India Private Limited
Data last updated:
Repro Labs India Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 28 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U85195TN2010PTC076747. Its GSTIN is 33AAECR8762M1ZU (Tamil Nadu). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Mahadev Suresh (Managing Director) and Dugganahalli Chikkaputtegowda Sindhu Shree.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.21/1 2nd Cross Street Minor Trustpuram Kodambakkam, Chennai, Tamil Nadu, India – 600024.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.62 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹31.89 Lakh (net margin 1.4%) and EBITDA of ₹88.95 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 14% over five years.
The company is associated with 1 brand: Repro Labs. As per MCA filings, the company has open charges of ₹5.75 Cr on record. Court records list 8 cases involving the company, including 7 filed by the company and 1 filed against it.
Repro Labs India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0038180). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website reprolabsindia.com.
Company details
CIN U85195TN2010PTC076747
Registration Number 076747
Incorporation Date 28 July 2010
ROC Chennai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-02-0038180
Recognitions & Rankings of Repro Labs India
Contact details
Repro Labs India Private Limited's registered office is in Chennai, Tamil Nadu. Its website is reprolabsindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo.21/1 2nd Cross Street Minor Trustpuram Kodambakkam, Chennai, Tamil Nadu, India – 600024
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Repro Labs India Private Limited, buy the company report.
Comprehensive company report
Repro Labs India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Repro Labs India operates one associated brand: Repro Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Repro Labs focuses on reproductive medicine services and equipment in India. | reprolabsindia.com |
Business activity
The main business activity of Repro Labs India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Repro Labs India Private Limited, buy the company report.
Financials of Repro Labs India Private Limited
FY 2024 filings availableRepro Labs India Private Limited reported revenue of ₹22.62 Cr (up 10% YoY) for FY 2025.
Revenue · FY 2025
₹22.62 Cr ▲ 10%
Net profit · FY 2025
₹31.89 Lakh margin 1.4%
EBITDA · FY 2025
₹88.95 Lakh margin 3.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 13%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 2%
5 years · compounded
▼ 1%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 10% growth in the latest year. EBITDA rose 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹88.95 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹31.89 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Repro Labs India Private Limited, buy the company report.
Board of directors of Repro Labs India Private Limited
Repro Labs India has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahadev Suresh Also directs: Repro Lifesciences LLP, Jones Academy of Clinical Embryology Private Limited, Gewalife Tech India Private Limited and 1 more | Managing Director | 28 Jul 2010 | 16 Years 3 Months | Current |
| Dugganahalli Chikkaputtegowda Sindhu Shree Also directs: Repro Fertnest Private Limited | Director | 18 May 2022 | 4 Years 5 Months | Current |
Peer comparison
Repro Labs India Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Advanov Pharma Private Limited | ₹22.68 Cr (FY 2024) | 107.0% | Ahmedabad, Gujarat, India | |||
| Baalark Meditrade Services Private Limited | ₹22.62 Cr (FY 2025) | -17.0% | Lucknow, Uttar Pradesh, India | |||
| Repro Labs India Private Limitedthis company | ₹22.62 Cr (FY 2025) | ₹31.89 Lakh | 1.4% | 10.0% | Chennai, Tamil Nadu, India | |
| Mesik Healthcare Private Limited | ₹22.45 Cr (FY 2025) | 6.0% | Bangalore, Karnataka, India | |||
| Jaymapp International Private Limited | ₹22.2 Cr (FY 2025) | 131.0% | Noida, Uttar Pradesh, India |
To see the full peer comparison of Repro Labs India Private Limited, buy the company report.
Auditor
Repro Labs India Private Limited is audited by V M B G & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V M B G & Co | FY 2023 | 016564S |
Shareholding
The shareholding of Repro Labs India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Repro Labs India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.75 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Mar 2023 | 100729130 | Axis Bank Limited | ₹1.68 Cr | Open | |
| 08 Nov 2021 | 100531974 | Canara Bank | ₹13 Lakh | Open | |
| 08 May 2020 | 100369468 | Axis Bank Limited | ₹2.86 Cr | Open | |
| 31 Dec 2016 | 100083302 | Others | ₹77.93 Lakh | Open | |
| 26 Sep 2012 | 10386867 | Syndicate Bank | ₹30 Lakh | Open |
To see the full charge records of Repro Labs India Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Repro Labs India Private Limited has 8 court cases on record: 7 filed by Repro Labs India, 1 filed against it. All cases are disposed.
Total cases
8
Filed by the company
7
Filed against the company
1
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 1 | 0 |
Cases on record (2 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Criminal miscellaneous application | Filed by the company | Disposed |
| District court, Chennai, Tamil Nadu | Criminal complaint | Filed against the company by State Represent by Drug Inspector G. Saravanan | Disposed |
To see the full case history of Repro Labs India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Repro Labs India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Repro Labs India has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAECR8762M1ZU | Tamil Nadu | Active | 01 Jul 2017 |
| 29AAECR8762M1ZJ | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Repro Labs India Private Limited, buy the company report.
Recent activity
Repro Labs India Private Limited has 5 board changes on record since 2010: 2 appointments and 3 cessations. The latest: Dugganahalli Chikkaputtegowda Sindhu Shree ceased to be Additional Director on 30 Sep 2022.
Charges
A charge with Axis Bank Limited of Rs. 168.00 Lakh registered on 24 Mar 2023 with Charge ID 100729130 was modified on 03 Jan 2025.
AGM
Repro Labs India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Repro Labs India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Charges
A charge with Axis Bank Limited amounted to Rs. 168.00 Lakh with Charge ID 100729130 was registered on 24 Mar 2023.
Ceased
Dugganahalli Chikkaputtegowda Sindhu Shree ceased to be Additional Director.
Appointed
Dugganahalli Chikkaputtegowda Sindhu Shree was appointed as Director.
Ceased
Soundararajan Sriraman ceased to be Additional Director.
Ceased
Karuppiah Sudhagar ceased to be Director.
Charges
A charge with Canara Bank amounted to Rs. 13.00 Lakh with Charge ID 100531974 was registered on 08 Nov 2021.
Charges
A charge with Axis Bank Limited amounted to Rs. 286.00 Lakh with Charge ID 100369468 was registered on 08 May 2020.
Charges
A charge with Others amounted to Rs. 77.93 Lakh with Charge ID 100083302 was registered on 31 Dec 2016.
Charges
A charge with Syndicate Bank of Rs. 30.00 Lakh registered on 26 Sep 2012 with Charge ID 10386867 was modified on 23 Oct 2014.
3 earlier events are in the company report.
Frequently asked questions
Repro Labs India is an active private limited company based in Chennai, Tamil Nadu, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 28 July 2010 (16+ years old) and is registered under CIN U85195TN2010PTC076747.
Repro Labs India has 2 current directors:
- Mahadev Suresh - Managing Director
- Dugganahalli Chikkaputtegowda Sindhu Shree - Director
The latest financial statements of Repro Labs India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Repro Labs India is 33AAECR8762M1ZU, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 29AAECR8762M1ZJ (Karnataka).
The CIN (Corporate Identification Number) of Repro Labs India is U85195TN2010PTC076747. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Repro Labs India has 8 court cases on record: 7 filed by the company and 1 filed against it.
Repro Labs India was incorporated on 28 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Repro Labs India by revenue are Advanov Pharma Private Limited, Baalark Meditrade Services Private Limited, Mesik Healthcare Private Limited, Jaymapp International Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Dugganahalli Chikkaputtegowda Sindhu Shree ceased to be Additional Director on 30 Sep 2022. Dugganahalli Chikkaputtegowda Sindhu Shree was appointed as Director on 18 May 2022. Soundararajan Sriraman ceased to be Additional Director on 18 May 2022. Repro Labs India has 5 board changes on record in total.
Yes, Repro Labs India is registered as a small enterprise under Udyam registration (number: UDYAM-TN-02-0038180).
Repro Labs India can be reached through the website reprolabsindia.com. Its registered office is in Chennai, Tamil Nadu, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages